应用结构化共识框架识别药学教育中的基础药物知识
本研究采用多阶段共识法(Lawshe法)确定药学课程基础药物清单。先由九人学术专家小组审阅整合治疗学课程中教授的1381种药物初始清单,再由十名代表不同临床环境的执业药师评估精炼清单,合并为19人共识小组。218种药物达成共识纳入:78种获一致共识(CVR=1.0),83种获近完全共识(CVR=0.895),57种达最低共识阈值(CVR=0.789)。与商业Top 300 Drugs清单比较,Jaccard相似指数0.408,重叠系数0.697;与商业清单的一致性随共识强度降低而下降,从一致共识药物的85%降至近完全共识的65%和最低阈值的56%,在阿片类镇痛药、静脉抗生素及急诊与重症药物方面存在系统性缺口。
要点
- 19人共识小组用Lawshe法确定218种基础药物:78种CVR=1.0,83种CVR=0.895,57种CVR=0.789。
- 共识最强的药物集中在心血管与血液、中枢神经系统和抗感染类别。
- 与商业Top 300 Drugs清单的Jaccard相似指数0.408、重叠系数0.697。
- 与商业清单一致性随共识强度下降:一致共识85%、近完全共识65%、最低阈值56%。
- 商业清单在阿片类镇痛药、静脉抗生素及急诊与重症药物方面存在系统性缺口。
适用人群与场景
- 药学课程教育者与课程设计者,用于确定需重点教授和评估的基础药物清单。
- 研究纳入整合治疗学课程中教授的1381种药物初始清单,由学术专家小组和执业药师共同评估。
诊断标准与关键阈值
- Lawshe法内容效度比(CVR)统计阈值:CVR=1.0为一致共识,CVR=0.895为近完全共识,CVR=0.789为最低共识阈值。
研究设计与关键结果
- 多阶段共识研究:九人学术专家小组审阅1381种药物初始清单,十名执业药师评估精炼清单,合并为19人共识小组。
- 218种药物达成共识纳入:78种CVR=1.0,83种CVR=0.895,57种CVR=0.789。
- 共识最强的药物类别为心血管与血液、中枢神经系统和抗感染。
- 与商业Top 300 Drugs清单比较:Jaccard相似指数0.408,重叠系数0.697。
- 与商业清单一致性:一致共识药物85%,近完全共识65%,最低阈值56%。
- 商业清单在阿片类镇痛药、静脉抗生素及急诊与重症药物方面存在系统性缺口。
证据类型、等级与局限
- 证据类型:多阶段共识研究(Lawshe法)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该研究提供了218种基础药物的验证共识框架和可复制方法,课程可据此开展聚焦的纵向评估,而非改变教学内容。
- 商业Top 300 Drugs清单在阿片类镇痛药、静脉抗生素及急诊与重症药物方面存在系统性缺口,课程设计时需注意此差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Foundational drug knowledge is a central expectation for pharmacy practice-readiness, yet programs lack consensus-based guidance on which medications to prioritize or how intensively to assess them. Programs often use volume-derived drug lists as a pragmatic starting point, but such lists may not fully reflect the breadth of medications encountered across diverse practice settings. The purpose of the study is to identify a consensus-based foundational drug list reflective of the breadth of pharmacy practice.
METHODS: A multi-phase consensus study was conducted using the Lawshe method to establish content validity of essential drugs for a pharmacy curriculum. An initial inventory of 1381 drugs taught across an integrated therapeutics curriculum was reviewed by a nine-member academic expert panel, followed by evaluation of the refined list by 10 practicing pharmacists representing diverse clinical settings. Responses were merged to form a 19-member consensus panel. Drugs meeting statistical thresholds for essentiality were grouped by strength of expert agreement. The resulting list was compared with a commercially available Top 300 Drugs list using the Jaccard Similarity index.
RESULTS: A total of 218 drugs achieved consensus inclusion: 78 reached unanimous consensus with a content validity ratio (CVR) = 1.0, 83 reached near-complete consensus (CVR = 0.895), and 57 met the minimum consensus threshold (CVR = 0.789). Cardiovascular and hematology, central nervous system, and anti-infective classes were most heavily represented among drugs with the strongest consensus. Comparison with the commercial list yielded a Jaccard Similarity index of 0.408 and an overlap coefficient of 0.697. Concordance with the commercial list declined as consensus strength decreased, from 85% among unanimously endorsed drugs to 65% at near-complete consensus and 56% at the minimum threshold, with systematic gaps in opioid analgesics, intravenous antibiotics, and emergency and critical care medications.
CONCLUSION: This study provides a validated, consensus-derived framework of 218 foundational drugs and a replicable methodology that programs may use or adapt. The primary curricular application operates through focused, longitudinal assessment rather than changes to taught content.
参考来源
- Shultz B, Sawyer K, Schriever A, et al. Identifying Foundational Drug Knowledge in Pharmacy Education Using a Structured Consensus Framework. J Am Coll Clin Pharm. 2026. PMID: 42423234. doi:10.1002/jac5.70260
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。